文献速递急性肾损伤慢性肾脏病

急性肾损伤后不良肾脏结局的长期风险:系统综述与荟萃分析

Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

该系统综述与荟萃分析纳入70项研究、共1 838 668例个体(其中急性肾损伤165 715例),评估急性肾损伤后慢性肾脏病发病、慢性肾脏病进展、肾衰竭及主要不良肾脏事件的风险。结果显示急性肾损伤患者上述结局风险均更高,且即使最低分期或最短持续时间的急性肾损伤患者慢性肾脏病发病或进展风险仍较高。

要点

  • 急性肾损伤患者慢性肾脏病发病风险升高(HR 2.36,95%CI 1.77-2.94)。
  • 急性肾损伤患者肾衰竭风险升高(HR 2.64,95%CI 2.03-3.25)。
  • 即使仅急性肾损伤1期或持续时间<3天,慢性肾脏病发病风险仍较高。

核心结论

  • 所有急性肾损伤个体的肾脏功能障碍风险均更高,风险估计因急性肾损伤分期、持续时间和临床场景而异,但最低分期或最短持续时间者慢性肾脏病发病或进展风险仍较高。

研究设计与样本

  • 系统检索PubMed和Embase,纳入至少报告一项急性肾损伤对比无急性肾损伤结局、随访至少1年的研究,共70项研究、1 838 668例个体(急性肾损伤165 715例),所有研究质量为中至高等。

主要发现

  • 慢性肾脏病发病:急性肾损伤25.8% vs 无急性肾损伤8.7%,HR 2.36(95%CI 1.77-2.94)。
  • 慢性肾脏病进展:急性肾损伤43.1% vs 无急性肾损伤35.6%,HR 1.83(95%CI 1.26-2.40)。
  • 肾衰竭:急性肾损伤2.9% vs 无急性肾损伤0.5%,HR 2.64(95%CI 2.03-3.25)。
  • 主要不良肾脏事件:急性肾损伤59.0% vs 无急性肾损伤32.7%,OR 2.77(95%CI 2.01-3.53)。
  • 急性肾损伤持续<3天者慢性肾脏病发病合并OR 2.37(95%CI 1.68-3.07),仅急性肾损伤1期者HR 1.49(95%CI 1.44-1.55)。

关键数值与推荐

  • 糖尿病、高血压、需要急性透析、心血管手术或冠状动脉疾病与更高的慢性肾脏病发病或进展风险相关。

临床怎么用

  • 作者认为需要制定量身定制的随访策略,以及时识别急性肾损伤后肾功能下降并启动肾脏保护措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is associated with increased risks of incidence or progression of chronic kidney disease (CKD), kidney failure (KF), or major adverse kidney events (MAKE), however, it remains unclear which individuals have higher risks. Hence, we systematically reviewed the literature to explore differences in kidney dysfunction risks between AKI stages, AKI durations, and clinical settings. METHODS: We performed a systematic search in PubMed and Embase to identify studies that examined at least one outcome of interest in individuals with AKI versus without AKI, with a minimum follow-up of one year. Hazard/odds ratios (HR/OR) were pooled using random effects models. Heterogeneity across patient and disease characteristics was examined using subgroup and meta-regression analyses. RESULTS: We searched 70 studies, encompassing 1 838 668 individuals, including 165 715 with AKI. All studies were of moderate to high quality. Individuals with AKI had higher risks of CKD incidence [AKI 25.8%/no AKI 8.7%; HR 2.36 [95% confidence interval (CI) 1.77-2.94)]], CKD progression [AKI 43.1%/no AKI 35.6%; HR 1.83 (95%CI 1.26-2.40)], KF [AKI 2.9%/no AKI 0.5%; HR 2.64 (95%CI 2.03-3.25)], and MAKE [AKI 59.0%/no AKI 32.7%; OR 2.77 (95%CI 2.01-3.53)]. The pooled effect estimates for CKD incidence after AKI lasting <3 days remained significant [OR 2.37 (95%CI 1.68-3.07)], even in individuals with AKI stage 1 only [HR 1.49 (95%CI 1.44-1.55)]. Diabetes mellitus, hypertension, requiring acute dialysis, cardiovascular surgery, or coronary artery disease were associated with higher CKD incidence or progression risks. CONCLUSIONS: Risks for kidney dysfunction were higher for all individuals with AKI. Risk estimates were heterogeneous between patient subgroups, based on AKI stage, AKI duration, and clinical setting, yet even individuals with the lowest stage or shortest duration of AKI remained at higher risk for CKD incidence or progression. This highlights the need to develop tailored follow-up strategies to recognize kidney function decline post-AKI and initiate kidney protective measures in a timely fashion.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Veltkamp DMJ, Porras CP, Gant CM, et al. Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant. 2025. PMID: 40424522. doi:10.1093/ndt/gfaf093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。